Das hereditäre diffuse Magenkarzinom

[1]  A. Kandulski,et al.  Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches , 2022, International journal of molecular sciences.

[2]  G. Kristiansen,et al.  Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status , 2020, Cancers.

[3]  Maria Sofia Fernandes,et al.  Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review , 2020, Cancers.

[4]  G. Sethi,et al.  The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges , 2019, Cells.

[5]  B. Shirts,et al.  Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. , 2019, JAMA oncology.

[6]  A. Talhouk,et al.  Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery , 2019, Familial Cancer.

[7]  F. Coulet,et al.  Clinical implications of CTNNA1 germline mutations in asymptomatic carriers , 2018, Gastric Cancer.

[8]  Carla Oliveira,et al.  Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants , 2018, Human mutation.

[9]  P. Fletcher,et al.  Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status , 2017, Gastrointestinal endoscopy.

[10]  Iris Lansdorp-Vogelaar,et al.  Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. , 2017, Gastrointestinal endoscopy.

[11]  F. Cardoso,et al.  Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Jonathan S Berg,et al.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American journal of human genetics.

[13]  R. van Hillegersberg,et al.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.

[14]  B. Fernandez,et al.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.

[15]  R. Bernards,et al.  An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer , 2013, The Journal of pathology.

[16]  R. Jeffrey,et al.  A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer , 2011, Annals of Surgical Oncology.

[17]  D. Huntsman,et al.  Hereditary diffuse gastric cancer , 2008, Cancer.

[18]  R. Jeffrey,et al.  CDH1 Truncating Mutations in the E-Cadherin Gene: An Indication for Total Gastrectomy to Treat Hereditary Diffuse Gastric Cancer , 2007, Annals of surgery.

[19]  M. Mulholland,et al.  Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. , 2006, Journal of the American College of Surgeons.

[20]  D. Macdonald,et al.  Hereditary cancers in children and ethical and psychosocial implications. , 2000, Journal of pediatric nursing.

[21]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[22]  S. Butz,et al.  An alpha-E-catenin gene trap mutation defines its function in preimplantation development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Takeichi.  Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[24]  R. Kemler.  From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. , 1993, Trends in genetics : TIG.